Alkem Laboratories Ltd
Mr. Sandeep Singh joined the Board in the year 2013; currently, he is serving the organization as its Managing Director. Mr. Singh has over 18 years of experience in the pharmaceutical industry. He spearheads the domestic as well as the international operations of the organization. In the year 2016, he was presented with the ‘Emerging Pharma Leader of 2016 Award’ by the Pharma Leaders in association with the Ministry of Health & Family Affairs, Government of India. In the year 2021, he was featured by ‘ET AND SPENCER STUART 40 under 40’.
This person is not in any offices
Alkem Laboratories Ltd
9 followers
Alkem Laboratories Limited is a pharmaceutical company. The Company is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products. The Company operates through two segments: pharmaceutical and investing. The Company produces generics, generic drugs, active pharmaceutical ingredients (APIs) and neutraceuticals, which it markets in India and approximately 50 countries internationally, primarily the United States. The Company offers various products, such as CLAVAM 375, CLAVAM BID DRY SYRUP, CLAVAM INJ 300MG, FREEAIR NASAL SPRAY, PAN 40MG INJECTION (VIAL), PAN/40MG TABLETS, PROWEL DRY SYRUP (30ML), TAXCLAV 100 DT TABLETS, SATROGYL O DRY SYRUP, XONE/500MG VAIL, MEROSURE KIT 500, MEROSURE 500 MG and ZADONASE, among others. The Company has approximately 16 manufacturing facilities, of which 14 manufacturing facilities are at geographically diversified locations in India and two in the United States.